My Treatment Approach: Recent Advances in the Treatment of Multiple Myeloma in Early Relapse : Episode 4
Clinical Implications of the IKEMA Trial in R/R MM
Dr Forsberg details the safety data and toxicity management strategies of the IKEMA clinical trial.
EP: 1.Patient Profile 1: A 63-Year-Old Female with Relapsed Multiple Myeloma
EP: 2.Treatment Options for Patients with Multiple Myeloma in Early Relapse
EP: 3.IKEMA Trial of Isatuximab plus Carfilzomib and Dexamethasone in R/R MM
Now Viewing
EP: 4.Clinical Implications of the IKEMA Trial in R/R MM
EP: 5.Selecting the Appropriate Patients With MM for Treatment With Isa-Kd
EP: 6.Treatment of Patients With MM and High-Risk Cytogenetics
EP: 7.Patient Profile 2: A 76-Year-Old Female with R/R MM
EP: 8.CANDOR Trial of Daratumumab Plus Carfilzomib and Dexamethasone in R/R MM
EP: 9.Selecting Patients for Treatment With DARA-Kd
EP: 10.Sequencing Therapies in Patients With R/R MM
EP: 11.Advice for Community Oncologists Treating Patients With R/R MM
Related Videos
Related Content
